Literature DB >> 30383176

Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model".

Mark R Trusheim1, William M Cassidy2,3, Peter B Bach4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30383176     DOI： 10.1001/jama.2018.15782

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

Review 1.  Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable.

Authors:  Radha K Dhiman; Madhumita Premkumar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

Review 2.  Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.

Authors:  Selin Ocal; Andrew J Muir
Journal:  Curr HIV/AIDS Rep       Date:  2020-02       Impact factor: 5.071

Review 3.  Closing the hepatitis C treatment gap: United States strategies to improve retention in care.

Authors:  Austin T Jones; Christopher Briones; Torrence Tran; Lisa Moreno-Walton; Patricia J Kissinger
Journal:  J Viral Hepat       Date:  2022-05-26       Impact factor: 3.517

4.  Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?

Authors:  Leonard Sowah; Christine Chiou
Journal:  AIDS Res Hum Retroviruses       Date:  2021-06-02       Impact factor: 1.723

5.  Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons.

Authors:  Sabrina A Assoumou; Abriana Tasillo; Claudia Vellozzi; Golnaz Eftekhari Yazdi; Jianing Wang; Shayla Nolen; Liesl Hagan; William Thompson; Liisa M Randall; Lara Strick; Joshua A Salomon; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 20.999

6.  Screening for Hepatitis C Virus: How Universal Is Universal?

Authors:  Ravi Jhaveri
Journal:  Clin Ther       Date:  2020-07-23       Impact factor: 3.393

7.  Medication Shortages During the COVID-19 Crisis: What We Must Do.

Authors:  Esther K Choo; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2020-04-03       Impact factor: 7.616

8.  Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan.

Authors:  Yueran Zhuo; Tomoyuki Hayashi; Qiushi Chen; Rakesh Aggarwal; Yvan Hutin; Jagpreet Chhatwal
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

Review 9.  Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease.

Authors:  Misha Angrist; Anna Yang; Boris Kantor; Ornit Chiba-Falek
Journal:  Life Sci Soc Policy       Date:  2020-10-12

10.  Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire.

Authors:  Andrew Blake; James E Smith
Journal:  JAMA Netw Open       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.